The tremendous health, equity, and cost burdens of diet-related cardiometabolic diseases (CMD), and the promise of healthier eating to address these burdens, are increasingly recognized. Many of the most promising and timely new diet-related interventions are in two large and growing domains: (a) health systems, who increasingly have vested interest in improving health and reducing costs through better nutrition; and (b) state-level actions, where innovations can often be more rapidly deployed and tested than at national levels. However, while health system and state-level actions have evidence supporting and informing their likely health benefits, much science remains uncertain.
Our research will focus on (1) estimating health impacts, costs, cost-effectiveness, and effects on disparities of specific health system strategies to improve diet and reduce CMD; (2) estimating health impacts, costs, cost-effectiveness, and effects on disparities of specific state-level policies to improve diet and reduce CMD; (3) assessing administrative and legal feasibility of health system and state strategies to improve diet and reduce CMD; and (4) disseminating top findings from the prior period, related grants, and this new work to relevant stakeholders in key legislative, agency, and advocacy positions.
More information is forthcoming.